First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment

Philip R. Clingan, Stephen P. Ackland, Daniel Brungs, Paul de Souza, Morteza Aghmesheh, Madhu B. Garg, Richard D. Ranson, Suzanne Parker, Rebecca Jokela, Marie Ranson

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science